Memorial Sloan Kettering Hematologic Oncologist Tamanna Haque

Tamanna Haque, MD

Areas of Expertise

Conditions I Treat

  • Leukemia
  • Acute lymphocytic leukemia (ALL)
  • Acute myeloid leukemia (AML)

My Specialties

  • Clinical trials
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I’m a hematologic oncologist who is an expert in treating and managing blood cancers and blood disorders. This includes acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. I also see patients for clonal hematopoiesis (CH) at our CH clinic. CH is a rare condition where a single blood cell develops a genetic mutation. This can lead to blood cancers such as myelodysplastic syndrome and acute myeloid leukemia.

Together with my team on the Leukemia Service, we provide care that is guided not only by each person’s needs but also by the latest treatment options. I see patients at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

Patients often have questions about how effective a treatment might be and the side effects that can come with it. I will speak openly and honestly with you about what to expect during your care journey. A cancer diagnosis can be a difficult time and I will take the time to get to know you and work with you to deliver the best care. My team and I will monitor you closely and work to make sure you are comfortable every step of the way.

I am passionate about finding new and better treatments for our patients. This drives me to take part in clinical research that can improve results for patients and help more and more people affected by blood cancer in the future.

What I Do at MSK

I’m a leukemia specialist, which is a doctor with special training in diagnosing and treating leukemia (loo-KEE-mee-uh). This cancer starts in tissue that forms blood, such as bone marrow.

  • Assistant Attending Physician
Areas of Expertise

Conditions I Treat

  • Leukemia
  • Acute lymphocytic leukemia (ALL)
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia (APL)
  • Chronic lymphocytic leukemia (CLL)
  • Chronic myeloid leukemia (CML)
  • Myelodysplastic syndrome (MDS)
  • Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
  • Hairy cell leukemia (HCL)
  • Systemic mastocytosis
  • Clonal hematopoiesis (CH)

My Specialties

  • Clinical trials
Education & Honors

Education

  • MD, SUNY Downstate

Residencies

  • Internal Medicine - Rutgers-Robert Wood Johnson University Hospital

Fellowships

  • Hematology and Medical Oncology - Montefiore Medical Center

Board Certifications

  • Internal Medicine
  • Hematology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Leukemia Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Haque’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Tamanna Haque discloses the following relationships and financial interests:

  • MD Education Ltd
    Professional Services and Activities
  • MorphoSys AG
    Professional Services and Activities
  • Servier
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures